EP3217869A1 - Scoring method based on improved signals analysis - Google Patents
Scoring method based on improved signals analysisInfo
- Publication number
- EP3217869A1 EP3217869A1 EP15797939.4A EP15797939A EP3217869A1 EP 3217869 A1 EP3217869 A1 EP 3217869A1 EP 15797939 A EP15797939 A EP 15797939A EP 3217869 A1 EP3217869 A1 EP 3217869A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- subject
- score
- matrices
- neural
- riemannian
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004458 analytical method Methods 0.000 title claims description 11
- 238000013077 scoring method Methods 0.000 title description 4
- 238000000034 method Methods 0.000 claims abstract description 139
- 230000001537 neural effect Effects 0.000 claims abstract description 138
- 239000011159 matrix material Substances 0.000 claims abstract description 83
- 238000000537 electroencephalography Methods 0.000 claims description 29
- 210000004556 brain Anatomy 0.000 claims description 24
- 230000000638 stimulation Effects 0.000 claims description 20
- 238000002595 magnetic resonance imaging Methods 0.000 claims description 12
- 239000013598 vector Substances 0.000 claims description 12
- 238000004497 NIR spectroscopy Methods 0.000 claims description 10
- 238000002600 positron emission tomography Methods 0.000 claims description 9
- 238000002566 electrocorticography Methods 0.000 claims description 8
- 238000002582 magnetoencephalography Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 7
- 238000002635 electroconvulsive therapy Methods 0.000 claims description 6
- 238000013548 repetitive transcranial magnetic stimulation Methods 0.000 claims description 6
- 238000011491 transcranial magnetic stimulation Methods 0.000 claims description 6
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- 206010010904 Convulsion Diseases 0.000 claims description 4
- 230000007383 nerve stimulation Effects 0.000 claims description 4
- 210000001186 vagus nerve Anatomy 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 3
- 230000004927 fusion Effects 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 31
- 230000000694 effects Effects 0.000 description 20
- 230000006870 function Effects 0.000 description 19
- 208000035475 disorder Diseases 0.000 description 17
- 201000010099 disease Diseases 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 230000007177 brain activity Effects 0.000 description 11
- 230000002490 cerebral effect Effects 0.000 description 11
- 238000012549 training Methods 0.000 description 10
- 238000010606 normalization Methods 0.000 description 9
- 238000012545 processing Methods 0.000 description 8
- 230000000007 visual effect Effects 0.000 description 8
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 7
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 7
- 206010022437 insomnia Diseases 0.000 description 7
- 230000035790 physiological processes and functions Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 5
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 230000004936 stimulating effect Effects 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 238000004590 computer program Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000024827 Alzheimer disease Diseases 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 208000000094 Chronic Pain Diseases 0.000 description 3
- 208000019695 Migraine disease Diseases 0.000 description 3
- 206010039897 Sedation Diseases 0.000 description 3
- 208000005298 acute pain Diseases 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000012886 linear function Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000006996 mental state Effects 0.000 description 3
- 230000036280 sedation Effects 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 230000003238 somatosensory effect Effects 0.000 description 3
- 238000010200 validation analysis Methods 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 2
- 208000018737 Parkinson disease Diseases 0.000 description 2
- 208000000323 Tourette Syndrome Diseases 0.000 description 2
- 208000016620 Tourette disease Diseases 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000002790 cross-validation Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000000626 neurodegenerative effect Effects 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 208000028173 post-traumatic stress disease Diseases 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010003805 Autism Diseases 0.000 description 1
- 208000020706 Autistic disease Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 208000012202 Pervasive developmental disease Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 208000029560 autism spectrum disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010013932 dyslexia Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 238000007519 figuring Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000001339 gustatory effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012067 mathematical method Methods 0.000 description 1
- 238000005399 mechanical ventilation Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000004007 neuromodulation Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000010223 real-time analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 238000013526 transfer learning Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
- A61B5/004—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
- A61B5/0042—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
- A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/242—Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents
- A61B5/245—Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents specially adapted for magnetoencephalographic [MEG] signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
- A61B5/372—Analysis of electroencephalograms
- A61B5/374—Detecting the frequency distribution of signals, e.g. detecting delta, theta, alpha, beta or gamma waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
- A61B5/375—Electroencephalography [EEG] using biofeedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
- A61B5/4082—Diagnosing or monitoring movement diseases, e.g. Parkinson, Huntington or Tourette
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
- A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7225—Details of analog processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7246—Details of waveform analysis using correlation, e.g. template matching or determination of similarity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/037—Emission tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
- A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
- A61B6/5217—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Definitions
- the present invention relates to a scoring method, especially a method for scoring the neural activity of a subject based on neural signals analysis in a Riemannian manifold.
- the present invention relates to a method for real time scoring of the neural signals of a subject with respect to a reference state. Said method may be used for external or self-paced modulation of the underlying brain activity.
- Ascertaining the position of the neural activity of a subject relative to a reference -or target- state in real time remains a challenge and presents many advantages. Said position relative to a reference state, estimated under the form of a score, may be subsequently used for self-paced modulation or external modulation.
- One of the key elements is the ability to reliably and robustly analyze and report the neural activity of a subject.
- neural signals are characterized through descriptor named covariance matrix. Covariance matrices constitute good indicators of the subject's brain activity.
- Barachant discloses in US 2012/0071780 a classification method for classifying neural signals, the method comprising the following steps:
- Barachant describes two-class and multiclass classifications.
- Barachant discloses a method of classifying neural signals in a Riemannian manifold.
- the principle consists in defining, on the Riemannian manifold, so-called "class center" points, for example PI and P2 corresponding to two distinct mental tasks: imagining moving a hand and imagining moving a foot.
- the Riemannian distance is calculated between the covariance matrix of a trial of cerebral activity that is to be classified and the corresponding class center point.
- classification step considers only the minimum of the distances to class centers.
- Similowski discloses a method for characterizing the physiological state of a patient from the analysis of the cerebral electrical activity of said patient.
- Similowski describes a method for detecting a physiological state of a patient deviating from a reference physiological state. Said method comprises first the determination of several reference matrices corresponding to a reference physiological state, and then the following steps are repeated in a loop:
- Barachant et al. disclose a method for classifying neural signals by assign them to the class having the minimal distance
- Similowski et al. disclose a method for detecting a physiological state by comparing the distances between the neural signals and reference states to a predefined threshold.
- One of the objects of the present invention is to report to a subject the position of its neural activity relative to a reference -or target- state in real time and optionally to enable said subject to modulate its neural activity towards said target state by self-paced modulation or external modulation.
- the present invention provides a method for scoring neural signals of a subject with respect to a reference state, with the score defined as a transformation of the distance, ensuring continuous and bounded values between predetermined bounds.
- the present invention provides a continuous feedback of the neural activity of the subject by reporting in real time the scoring of neural signals of the subject with respect to a reference state.
- the present invention continuously and boundedly scores the neural signals with respect to a reference state, thereby continuously positioning the neural activity of a subject with regard to a single reference state.
- the transformation of the distance into a score is made thanks to a non-linear function, with potential hyper-parameters which are adapted to the baseline state of the subject. It allows to have a score living in the complete range between two predetermined bounds, avoiding to always give a good score to a subject, or inversely, always a bad score.
- the present invention discloses an improved scoring method.
- the neural activity of a subject is analyzed in real time and the position of the neural activity with respect to a reference state is continuously and reliably reported to said subject by means of a bounded, continuous score.
- Said subject may in return modulating and modifying its neural activity and monitoring said evolution in real time in order to conduct its neural activity towards said reference state, either by self -paced modulation or external modulation.
- the said score is bounded between two predetermined values a and b.
- the method further comprises the computing of a score s, said score s being continuous, computed in real time, bounded between two predetermined values a and b, and based on at least one of the distances dk computed in step iv.
- the score is further based on at least one of the distances d r obtained as follows :
- the score is based on at least one of the distances dk, on the geometric means of the distances d r and on the geometric standard deviation of the distances d r .
- At least two neural signals are obtained, filtered in at least two frequency bands and concatenated.
- the covariance matrix is a spatiofrequential covariance matrix.
- the at least one neural signal is obtained by electrocorticography, electroencephalography, magnetoencephalography, magnetic resonance imaging, near-infrared spectroscopy, positron emission tomography or stereoelectroencephalography.
- the score s is continuous and bounded.
- step i also comprises preprocessing of said at least one neural signal, preferably by filtering.
- the covariance matrix is a spatiofrequential covariance matrix.
- the Riemannian distances are estimated in the Riemannian manifold of symmetric positive definite matrices of dimensions equal to the dimensions of said covariance matrix.
- the Riemannian clustering method is selected from mean- shift, k-means, average or principal geodesic analysis.
- the present invention also relates to a system for self-paced modulation or external modulation of neural activity of a subject comprising:
- acquisition means for acquiring at least one neural signal from a subject
- computing device for implementing the method according to the present invention
- the present invention also relates to a method for self -paced modulation of neural activity of a subject in order to reach a reference state, said method comprising continuously:
- the said method for self-paced modulation is non- therapeutic.
- the present invention also relates to a method for external modulation of neural activity of a subject in order to reach a reference state, said method comprising:
- the said method for external modulation is non- therapeutic.
- the external modulation is applied by deep brain stimulation, electroconvulsive therapy, magnetic seizure therapy, transcranial direct current stimulation, transcranial magnetic stimulation, repetitive transcranial magnetic stimulation or vagus nerve stimulation.
- the external modulation also comprises indirect brain stimulation such as any sensory stimulation (auditory, visual, somatosensory).
- Base state refers to a mental state of a subject, a population of subjects or a population of non-reference states which is not the reference state.
- “Calibrated score” refers to a score s, which mean and standard deviation are set to desired values using a mathematical transformation wherein coefficients are derived from previously acquired data.
- Computer device refers to a computer-based system or a processor-containing system or other system that can fetch and execute the instructions of a computer program.
- Discomfort refers to the absence or to a decrease in the feeling of ease or well- being. In one embodiment, a discomfort may be related to the presence of pain.
- Disease, disorder or condition refers to a defective state of health, wherein a physical or mental system is affected.
- Electrode refers to a conductor used to establish electrical contact with a nonmetallic part of a circuit.
- EEG electrodes are small metal discs usually made of stainless steel, tin, gold, silver covered with a silver chloride coating; there are placed on the scalp in specific positions.
- Electroencephalogram or “EEG” refers to the tracing of brain waves, by recording the electrical activity of the brain from the scalp, made by an electroencephalograph.
- Electroencephalograph refers to an apparatus for detecting and recording brain waves.
- Epoch refers to a determined period during which neural signals are acquired.
- “External or induced modulation” refers to the modulation of the brain activity which is not induced by the subject. Said modulation may comprise the following methods:
- DBS o Deep brain stimulation
- TMS Transcranial magnetic stimulation
- rTMS o Repetitive transcranial magnetic stimulation
- VNS o Vagus nerve stimulation
- External modulation also comprises any method of stimulation known by one skilled in the art which affect the brain's activity, e.g. drugs (sedation) or interventions (mechanical ventilation). Such stimulation may also indirectly affect the brain via sensory neural afferences: acoustic, visual, somatosensory stimulations. External modulation may also comprise simultaneous stimulation of elements of the two hemispheres of the brain at different frequencies of phase in order to elicit brain activity at frequency of interest in specific area of the brain (e.g. binaural beats for auditory stimulation).
- Neurological signals refers herein to the signals obtained by measuring neural activity. Said neural activity may be measured by:
- EoG Electrocorticography
- Magnetic resonance imaging diffusion MRI, perfusion MRI, functional MRI (fMRI);
- NIRS Near-infrared spectroscopy
- PET Positron emission tomography
- SEEG Stereoelectroencephalography
- the present invention refers to the acquisition and treatment of at least one neural signal or of neural signals
- Real time refers to a process for which the output is given within a time delay that is considered as smaller than the time delay required to perform the underlying task of modulation adequately. Therefore for self-paced modulation, real time refers to a process implemented in less than 700ms, preferably less than 500ms, more preferably less than 400ms, even more preferably less than 250ms. For external modulation real time may refer to a process implemented in less than lOmin, less than lmin; less than 30s, less than Is or less than 700ms, depending on the frequency of the external modulation.
- Reference state refers to the modeling of a cerebral state of a subject or a population of subjects carrying out a determined task, such as for example eyes-open resting, eyes-closed resting, relaxing, meditating, concentrating, focusing on a specific thought...
- Riemannian manifold refers to a differentiable topological space that is locally homeomorphic to a Euclidean space, and over which a scalar product is defined that is sufficiently regular.
- the scalar product makes it possible to define a Riemannian geometry on the Riemannian manifold.
- Score refers to any value obtained or computed on a raw distance according to the present invention.
- the score is a bounded value which characterizes the position of the neural activity of a subject with respect to a reference state.
- the score is a value understandable to a subject, living on the complete range between two defined values.
- Self-paced modulation refers to the modulation of the brain activity induced by the subject.
- self-paced modulation has the same meaning as neurofeedback and refers to the ability for the subject to control its brain electrical activity by manipulating in real time the score s.
- Self -paced modulation may include cognitive strategy such as predefined instructions given to the subject.
- Subject refers to a mammal, preferably a human. In the sense of the present invention, a subject may be a patient, i.e. a person receiving medical attention, undergoing or having underwent a medical treatment, or monitored for the development of a disease.
- SPD Symmetric positive definite
- An SPD matrix of dimensions C*C has C(C+l)/2 independent elements; it may therefore be locally approximated by an Euclidian space of C(C+l)/2 dimensions. It is possible to show the SPD space has the structure of a Riemannian manifold. It is known that covariance matrices are symmetric positive definite matrices.
- Treating” or “treatment” or “alleviation” refers to both therapeutic treatment and prophylactic or preventative measures; wherein the object is to prevent or slow down (lessen) the targeted pathologic condition or disorder.
- Those in need of treatment include those already with the disorder as well as those prone to have the disorder or those in whom the disorder is to be prevented.
- a subject or mammal is successfully "treated” if, after receiving the treatment according to the methods of the present invention, the patient shows a lower score.
- the neural signals are acquired using magnetic resonance imaging (MRI), preferably fMRI, diffusion MRI or perfusion MRI.
- MRI magnetic resonance imaging
- NIRS near-infrared spectroscopy
- the neural signals are acquired using magnetoencephalography (MEG).
- MEG magnetoencephalography
- ECG electrocorticography
- EEG electroencephalography
- various types of suitable headsets or electrode systems are available for acquiring such neural signals.
- the neural signals are acquired using positron emission tomography (PET).
- the neural signals are acquired using stereoelectroencephalography (SEEG).
- the neural signals are acquired using implanted microelectrod arrays.
- the neural signals are acquired using deep brain implants. According to one embodiment, the neural signals are acquired using any cerebral imaging technique known by one skilled in the art. According to one embodiment, the neural signals are acquired using a set of sensors and/or electrodes. According to one embodiment, the neural signals are acquired by at least 4, 8, 10, 15, 16, 17, 18, 19, 20, 25, 50, 75, 100, 150, 200, 250 electrodes.
- the analyzed neural signals are raw neural signals or reconstructed neural signals.
- the analyzed neural signals are reconstructed from raw signals prior to analyze.
- the neural signals are obtained from reconstructed neural signals by any method known by one skilled in the art.
- the neural signals are acquired using positron emission tomography (PET).
- PET positron emission tomography
- LORETA low resolution brain electromagnetic tomography
- the overall acquisition time is subdivided into periods, known in the art as epochs.
- Each epoch is associated with a matrix X e M C*N , representative of the spatiotemporal signals acquired during said epoch.
- a spatiotemporal neural signal X e M C*N is composed of C channels, electrodes or sensors and N time samples.
- a subject is fitted with C electrodes for neural signals acquisitions.
- successive epochs are overlapped.
- the covariance matrix is a spatial covariance matrix.
- the spatial covariance matrix may be computed as follows:
- the spatial covariance matrix is computed using any method known by the skilled artisan, such as those disclosed in Barachant A. Commande robuste d'un effecteur par une interface Marina- machine EEG asynchrone, PhD. Thesis, Universite de Grenoble: FR, 2012.
- the signal is pre-processed.
- the signal is centered.
- the signal is filtered.
- the signal is denoised.
- the signal is cleaned.
- the signal is frequency-filtered.
- the cut-off frequencies of the frequential filtering are chosen arbitrarily. According to another embodiment, the cut-off frequencies of the frequential filtering are optimized thanks to a preliminary frequential study.
- the covariance matrix is normalized. According to one embodiment, the covariance matrix is trace-normalized, which makes its trace equal to 1 : trace (M)
- the covariance matrix is determinant-normalized, which makes its determinant equal to 1 :
- the normalization step especially the determinant normalization allows a session-to- session and/or a subject-to-subject transfer learning: it removes a part of variabilities from one recording to another.
- the method of the invention scores in real time at least one neural signal. Said at least one neural signal is filtered in at least one frequency band.
- the method of the invention scores in real time at least two neural signals, filtered in at least two frequency bands. Said at least two filtered neural signals are further concatenated.
- the extended signal X £ KL CF*N is defined as the vertical concatenation of the filtered signals:
- the covariance matrix is a spatiofrequential covariance matrix.
- the spatiofrequential covariance matrix M £ KL CF * CF is computed as follows:
- the spatiofrequential covariance matrix can be normalized, as previously described, by its trace or its determinant.
- the step of computing a covariance matrix of the neural signals comprises computing covariance matrix of said neural signals on overlapped window.
- the step of computing a covariance matrix of the neural signals comprises computing a spatio-frequential covariance matrix of said neural signals on overlapped window, and normalizing said spatio-frequential covariance matrix.
- Each covariance matrix associated with a given epoch is considered to be point of a Riemannian manifold.
- distance and means calculation are required.
- the metric used for covariance matrices has been detailed in Forstner W, Moonen B. A metric for covariance matrices. Quo vadis geodesia, pp. 113-128, 1999.
- the Riemannian distance is computed using any other distances known by one skilled in the art, such as those described in Li Y, Wong KM. Riemannian Distances for Signal Classification by Power Spectral Density. IEEE Journal of selected topics in signal processing, vol.7, No.4, August 2013. According to one embodiment, the Riemannian distances are estimated on the Riemannian manifold of symmetric positive definite matrices of dimensions equal to the dimensions of the covariance matrices.
- the P covariance matrices of the database are covariance matrices of neural signals characteristics of a reference state for different subjects and/or different sessions of neural signals acquisition.
- the Riemannian clustering method is selected from Mean- shift, k-means, average or principal geodesic analysis.
- Mean Shift over Riemannian manifold is performed.
- Mean Shift over Riemannian manifold is performed as disclosed in Subbarao et al. Nonlinear Mean Shift over Riemannian Manifolds. Int J Comput Vis, vol. 84, pages 1-20 (2009).
- the Mean Shift is performed iteratively.
- the K reference covariance matrices (also called modes) are obtained by Mean-Shift as follows:
- a computes the P distances d ⁇ M q , X p between M q and each matrix X p ; b. estimating the mean shift vector m /l (M (? ) as the weighted sum of tangent vectors
- the threshold value is selected in order to ensure convergence of the algorithm and is preferably ranging from 10 "1 to 10 "3 .
- k-means over Riemannian manifold is performed.
- k-means over Riemannian manifold is performed as disclosed in Congedo M. EEG Source Analysis, HDR, Universite de Grenoble: FR, 2013. According to one embodiment, the k-means is performed iteratively.
- the K reference covariance matrices are obtained by K- means as follows: i. defining the hyper-parameter K;
- At least one supplemental reference covariance matrix is subject- specific.
- at least one supplemental reference covariance matrix is obtained by estimating the Riemannian means of the covariance matrices obtained from a calibration session of the subject. Said embodiment enables to provide a feedback that falls within acceptable and stimulating ranges of activity for the following session of the subject.
- the score is bounded between two predetermined values a and b.
- the score always lies in the complete range of potential values, thereby avoiding to give a quasi-constant score to a subject, for example, always a good score, or inversely, always a bad score. Said optimal use of the available range of score values strongly enhances neurofeedback efficiency.
- the score s is calibrated.
- Calibration is the process of finding a relationship between an unknown quantity (a baseline activity of any subject at a given time) and a known quantity such as the operational range of a modulation device (for instance a voltage for a tDCS device, the volume of a speaker, or the lower and upper bounds of a display).
- the calibration process usually controls for the "bias" (the average departure from zero, or mean) and variance (the squared average departure from the mean/bias).
- the unknown quantity is usually characterized by a distribution (in the present case, distribution of Riemannian distances computed from a baseline session) that can be summarized by statistics such as the mean and standard deviation.
- the calibration procedure can therefore be expressed in terms of finding the mapping function transforming this baseline (uncontrolled) distribution into the operating range of a modulation device such as a current stimulator, a speaker, a screen,...
- a modulation device such as a current stimulator, a speaker, a screen,...
- it requires the target distribution to be bounded between two values.
- the final distribution makes optimal use of the available range of operating values. So that variance within those bounds is maximized.
- Said database comprises neural signals obtained from different subjects and/or different sessions of neural signals acquisitions in a known baseline state.
- the database comprises covariance matrices of neural signals corresponding to a baseline state obtained from a previous session of neural signals acquisitions of the subject.
- the score is calibrated in a subject- specific manner.
- the score s is calibrated in a subject- specific manner. Said embodiment enables to provide a feedback that falls within acceptable and stimulating ranges of activity for the following session of the subject.
- the score is based on at least one of the distances dk, on the geometric means of the distances d r and on the geometric standard deviation of the distances d r .
- the score s is estimated using a bounded function associating a score to a given standardized z-score.
- said function belongs to the family of sigmoid functions.
- said function is a logistic function, preferably: b— a
- said bounds a, b are predetermined (i.e. they are fixed as parameters).
- the score s is strictly bounded between a and b wherein a is preferably equal to 0 and b is preferably equal to 10.
- Another non-linear functions can be chosen to obtain a score from a z-score, such as generalized logistic function, hyperbolic tangent function, arctangent function, error function, and all other functions belonging to the family of sigmoid functions.
- the transformation of the distance into a score is made thanks to a z-score standardization and then a non-linear function, which gives a score adapted to the relative state of the subject. It allows to have always a score living in the complete range of potential values, avoiding to give a quasi-constant score to a subject, for example, always a good score, or inversely, always a bad score. Capturing evolutions around to the relative state of the patient, the optimal use of the available range of score values is necessary for neurofeedback efficiency.
- the score s is estimated using a logistic function, preferably:
- a database comprising baseline covariance matrices of neural signals corresponding to a non-reference or non-target state.
- Said database comprises neural signals obtained from different subjects and/or different sessions of neural signals acquisitions in a known baseline state.
- the largest distance among said Riemannian distances is then referenced to as d max .
- the parameter ⁇ can be chosen such that the sigmoid function associates to the distance d max a bounded score, preferably equal to 9.5.
- the score s is calibrated in a subject- specific manner.
- the database comprising covariance matrices of neural signals obtained from different subjects and/or different sessions of neural signals acquisitions in a known baseline state is replaced by covariance matrices obtained from a previous session of neural signals acquisitions of the subject.
- Said embodiment enables to provide a feedback that falls within acceptable and stimulating ranges of activity for the following session of the subject.
- the score s is strictly bounded between a and b wherein a is preferably equal to 0 and b is preferably equal to 10.
- the score s is not binary, coming from distances thresholding. According to one embodiment, the score s is not a class label, coming from a multiclass classification.
- the present invention is implemented with a computer program stored on a computer-readable media for directing operation of a computing device.
- the computer program comprises neural signal acquisition capabilities, preferably ECoG, EEG, MEG, MRI, NIRS, PET or SEEG acquisition capabilities.
- the computer program communicates with a system collecting neural signal data, preferably ECoG data, EEG data MEG data, MRI data, NIRS data, PET data or SEEG data.
- the present invention also relates to a method for self -paced modulation of neural activity of a subject in order to reach a reference state, said method comprising continuously:
- the subject By reporting in real time to the subject a score s, the subject is able to control the brain electrical activity such that the score s can be manipulated by the subject in real time.
- instructions are given to the subject during the session of self-paced modulation; said instructions includes, but are not limited to, relax, breathe normally, remain quiet, avoid eye movement, avoid muscle tension, avoid sucking movements, avoid chewing, or avoid any movement.
- no instructions are given to the subject during the session of self-paced modulation.
- the present invention also relates a method for external modulation of neural activity of a subject in order to reach a reference state, said method comprising:
- the external modulation is applied in order to minimize the score s.
- the method for external modulation of neural activity of a subject in order to reach a reference state is not therapeutic.
- the trainer may be a physician or an automated device applying the external modulation to the subject.
- the external modulation is applied by indirect brain stimulation, deep brain stimulation (DBS), electroconvulsive therapy (ECT), magnetic seizure therapy (MST), transcranial direct current stimulation (tDCS), transcranial magnetic stimulation (TMS), repetitive transcranial magnetic stimulation (rTMS) or Vagus nerve stimulation (VNS).
- the external modulation comprises indirect brain stimulation such as any sensory stimulation (auditory, visual, somatosensory).
- the present invention also relates a system for self-paced modulation or external modulation of neural activity of a subject comprising:
- the acquisition means comprises any means known by one skilled in the art enabling acquisition (i.e. capture, record and/or transmission) of neural signals as defined in the present invention, preferably electrodes or headset as explained hereabove.
- the acquisition means comprises an amplifier unit for magnifying and/or converting the neural signals from analog to digital format.
- the computing device comprises a processor and a software program.
- the processor receives digitalized neural signals and processes the digitalized neural signals under the instructions of the software program to compute the score s.
- the computing device comprises memory.
- the computing device comprises a network connection enabling remote implementation of the method according to the present invention.
- neural signals are wirelessly communicated to the computing device.
- the output means wirelessly receives the score s from the computing device.
- the output means comprise any means for reported the score s.
- the score s is reported using anyone of the senses of the subject: visual means, auditory means, olfactory means, tactile means (e.g. vibratory or haptic feedback) and/or gustatory means.
- the score s is reported using a display such as a screen: a smartphone, a computer monitor or a television; or a head-mounted display.
- the reporting of the score s enables the subject to be aware of the right direction of the training.
- the reporting of the score s comprises a visual reporting wherein a target, representing the real-time score s of the subject, is displayed, said target moving towards or away from a location representing a target score defined by the reference state.
- a sound is reported to the subject.
- the sound can be a simple beep, water flowing, waves, rain, dongs, or any other sound which can be modulated in amplitude or frequency.
- an object on the screen which position, size, color, or any other parameters can be modulated by said score s, is reported to the subject.
- the subject For instance it can be the representation of a plane, the altitude of which is modulated by the score s.
- the system and/or the method for self-paced modulation and/or external modulation is used in homecare or in clinical use.
- the present invention also relates to the use of the system for self-paced modulation or external modulation for alleviating discomfort of a subject.
- the self-paced modulation method and/or the external modulation method is for alleviating, or for use in alleviating discomfort in a subject.
- the present invention also relates to a method for alleviating discomfort in a subject, comprising the use of the system for self-paced modulation or external modulation of the invention.
- discomfort is psychiatric discomfort such as anxiety and stress.
- the system and/or method for self-paced modulation and/or external modulation is used for alleviating chronic or acute pain, migraines and depression.
- the system and/or the method for self-paced modulation and/or external modulation is used in order to reach the following target state: relaxation.
- the discomfort to be alleviated may be stress or anxiety.
- the present invention also relates to the system for self-paced modulation or external modulation for treating or for use in treating a condition, a disorder or a disease such as those described hereafter in a subject, preferably in a patient in need thereof.
- the self-paced modulation method and/or the external modulation method is used for treating or alleviating conditions, disorders or diseases of patients.
- the present invention also relates to a method for treating a condition, disorder or disease in a subject in need thereof, comprising the use of the system for self-paced modulation or external modulation of the invention.
- condition, disorder or disease that may be treated using the self-paced modulation method and/or the external modulation method of the invention include, but are not limited to neurodegenerative conditions, disorders or diseases, psychiatric conditions, diseases or disorders, primary insomnia, chronic or acute pain, epilepsy, Tourette's syndrome, migraines and depression.
- said condition, disorder or disease to be treated is a neurodegenerative condition, disorder or disease, such as for example Parkinson' s disease or Alzheimer's disease.
- the system and/or the method for self-paced modulation and/or external modulation enables treating Parkinson disease using surface and invasive EEG-based neuromarkers to reduce excess of beta activity.
- the system and/or method for self-paced modulation and/or external modulation enables treating Alzheimer's disease to reduce observed neuromarkers of Alzheimer's disease and increase brain fitness.
- said condition, disorder or disease o be treated is a psychiatric condition, disease or disorder, such as for example attention- deficit/hyperactivity disorder, pervasive developmental disorder, autism, post-traumatic stress disorder, addiction and sleep disorder.
- the system and/or method for self-paced modulation and/or external modulation enables treating post-traumatic stress disorder by reducing the stress and amplification of inhibitory/filtering circuits for external stimuli.
- the system and/or method for self-paced modulation and/or external modulation enables treating attention deficit/hyperactivity disorder thanks to neuromodulation of concentration and the learning of cerebral pathways.
- said condition, disorder or disease to be treated is selected from primary insomnia, chronic or acute pain, epilepsy, Tourette's syndrome, migraines and depression.
- the system and/or method for self -paced modulation and/or external modulation enables treating Primary insomnia thanks to the identification of the different stages preceding the onset of sleep and the dynamic feedback of said stages.
- the system and/or method for self-paced modulation and/or external modulation enables treating depression thanks to the reduction of depression neuromarkers and the balance of symmetrical EEG activity.
- the system and/or method for self-paced modulation and/or external modulation is used for improving the sedation in intensive care unit, in operation theatre or in general ward.
- the present invention thus also relates to a method for improving the sedation in intensive care unit, in operation theatre or in general ward, comprising the use of the system and/or method for self -paced modulation and/or external modulation of the invention.
- the system and/or method for self-paced modulation and/or external modulation is used for physical rehabilitation by activation and re- enforcement of pre-motor neural networks prior to trans-magnetic stimulation.
- the present invention also relates to a method of physical rehabilitation, comprising the use of the system and/or method for self -paced modulation and/or external modulation of the invention.
- the system and/or method for self-paced modulation and/or external modulation is used for improving some of patient's specific cerebral activity meaning.
- the present invention thus also relates to a method for improving the specific cerebral activity meaning of a patient, comprising the use of the system and/or method for self-paced modulation and/or external modulation of the invention.
- the system and/or the method for self-paced modulation and/or external modulation is used for improving skills of a subject, such as, for example, in healthy subjects (i.e. a subject that does not present any discomfort or disease, disorder or condition such as, for example, the ones listed hereinabove), such as precision.
- the present invention thus also relates to methods for improving specific cerebral activity meaning, and/or for improving skills of a subject, comprising using the system and/or the method for self-paced modulation and/or external modulation of the invention.
- OpenViBE platform is a software for BCI (Brain Computer Interface) and real time neurosciences. It provides components for digital signal processing and visualization of EEG signal. It can be extended with modules in C++, Matlab and Python.
- Example 1 Validation of the system and method for self-paced modulation of the neural activity of a subject
- the system and method for self-paced modulation i.e. neurofeedback
- the target mental state was the relaxation, i.e. a state wherein the subject is free from tension and anxiety.
- EEG data is composed of subject- specific sessions wherein each session is divided in two parts: relaxation and concentration.
- the purpose of the technique is to extract reference matrices on a training set (some EEG time-windows chosen randomly during the relaxation period), and to than apply these reference to test data (EEG time-window not included in the training set).
- the present method will be considered successful if the reference model accurately identifies relaxation period on the unseen data (i.e. the test set).
- the electroencephalography (EEG) data was collected using an Emotiv EPOC headset: the 14 electrodes were approximately located at the extended 10/20 locations AF3, F7, F3, FC5, T7, P7, 01, 02, P8, T8, FC6, F4, F8, AF4.
- the EPOC headset uses a Common Mode Sense (CMS) electrode at F4 location and a Driven Right Leg (DRL) electrode at F3 that can be related to the ground and reference in more traditional acquisition systems. Electrodes impedances were controlled visually with the EPOC Control Panel so that all sensors show "green”. Signals are internally digitized at 2048Hz (16-bit) and subsequently low pass filtered and down sampled to 128Hz before transmission to the acquisition module.
- the headset was connected wirelessly to the participant laptop and interfaced with the NeuroRT Suite.
- Data is composed of 61 sessions, divided in two parts by direction for the user displayed on the main screen:
- EEG data is acquired in Paris and Rennes (France), from 61 healthy participants aged between 23 and 34 years old.
- - spatio-frequential covariance matrices are extracted on overlapped epochs of 2s all 0.0625s and are regularized; and - the Riemannian average covariance matrix is computed on this relaxation part, called subject average matrix.
- This average matrix is then normalized, i.e. trace normalized or determinant-normalized.
- one average matrix is obtained per participant totaling to 61 independent matrices.
- the goal is to extract reference matrices on the training set by clustering, and to test them on the test set.
- the method according to the present invention will be considered successful if the test subject is closer from references during the relaxation part than during the concentration part.
- a clustering algorithm (Riemannian average, Riemannian K-means, Riemannian Mean-Shift) is applied to estimate K reference matrices on the training set.
- spatio-frequential covariance matrices are extracted on epochs of the relaxation and concentration parts, as previously described, and normalized. The mimimum distance between the K references matrices and each epoched covariance matrix is recorded.
- the geometric mean of distances is computing for the relaxation and then for the concentration part.
- the neurofeedback is considered as efficient if the geometric mean of distances during relaxation is lower than the one during concentration. This evaluation is performed for the 61 test subjects.
- subject average spectrum For each relaxation session, an averaged spectrum is computed, called subject average spectrum.
- mean and standard deviation of subject average spectra of the training set are computed.
- spectra are extracted on epochs of the relaxation and concentration parts, as previously described. They are then transformed in z-score using the mean and the standard deviation estimated on the training set.
- the Frobenius norm of each z- scored spectrum is recorded as distance to relaxation qEEG model.
- the mean of distances is computing for the relaxation and then for the concentration part.
- the neurofeedback is considered successful if the mean of distances during relaxation is lower than the one during concentration. This evaluation is performed using the exact same folds than previously described for the 61 subjects.
- results obtained by Riemannian clustering are superior to traditional qEEG; thereby validating the relevance and the efficiency of the method according to the present invention.
- Table 1 Results with a trace normalization of matrices.
- a specific recording modality ECG, EEG, MEG, MRI NIRS or PET
- ECG EEG
- MEG MEG
- MRI NIRS Magnetic MRI
- PET PET
- the specific activity of a subject can be compared to the target according to the method of the present invention and the brain activity can be self -paced to reach the desired objective.
- the frequency and the length of sessions will vary for each application an on a case-by-case basis.
- a specific recording modality ECG, EEG, MEG, MRI NIRS or PET
- ECG EEG
- MEG MEG
- MRI NIRS Magnetic MRI
- PET PET
- the specific activity of a subject can be compared to the target according to the method of the present invention and the brain activity can be externally modulated to reach the desired objective.
- the frequency and the length of sessions will vary for each application an on a case-by-case basis.
- Example 4 Detailed example for ADHD (Attention Deficit Hyperactivity Disorder)
- ADHD tention Deficit Hyperactivity Disorder
- EEG data is collected from a population of healthy volunteers during a specific condition: eyes open, eyes closed, concentration or relaxation for instance.
- the collection of this reference dataset is done once and tries to cover equally the age ranges of interest for the application.
- the recording of each subject will last roughly 30 minutes and will use traditional EEG acquisition system such as those described hereabove, in particular Epoc commercially available from Emotiv.
- Each 2s-long time window from this dataset will be converted into a covariance matrix and placed as a point in the Riemannian manifold.
- the artefactual periods will be identified iteratively.
- ADHD children and teenagers are usually referred to medical and paramedical practitioners who handle comorbid conditions such as dyslexia.
- the treatment of ADHD is mostly composed of medication but recent evidence suggest that these patients exhibit different EEG patterns and neurofeedback protocols have therefore been implemented to correct these towards more normal electric activity of the brain. We offer to do so using a more accurate and intuitive feedback towards normal activity using the aforementioned reference state.
- the application controls the signals and ensures that the data is collected adequately.
- a baseline recording makes sure that signals are not artefacted beyond acceptable limits. If so, feedback is provided to the operator in the form of auditory and visual instruction to indicate how to account for it.
- the operator decides of the length of the neurofeedback sessions and a type of feedback is chosen where the score s, obtained from the method according to the present invention can be represented by (non-exhaustive list):
- the sound can be a simple beep, water flowing, waves, rain, dongs, or any other sound which can be modulated in amplitude or frequency;
- Example 5 Detailed example for primary insomnia
- Primary insomnia is a type of insomnia that could not be related to any organic origin. It was shown that population of patients with primary insomnia have increased beta activity in frontal areas prior to sleep. Consequently, this population is a good candidate for neurofeedback protocols, the true impact of which can only be seen for at-home applications.
- Each session would happen shortly before bedtime on a voluntary basis or following a medical posology.
- the subject will use an easy-to-use general consumer EEG device that we will learn to setup on him. He logs on onto a secured website that connects to the EEG headset and retrieves his personal data and parameters. Data is streamed to a remote real time analysis server and extracted information is sent back to the web application, which for instance can display information to guide to subject to obtain good signal quality: for instance a real time 2 or 3D topographic heat map of signal quality. Figuring out good signals should take less than 5 minutes.
- the subject can choose between several feedback applications that will work exactly like the applications described above.
- his brain activity is compared to the previously identified reference covariance matrices and the computed distance to those is returned in the form of a feedback that can be visual or auditory (in a similar manner than what was described for ADHD in clinic).
- the patient can select the length of the session.
- the web page stores and displays information related to performance, evolution of the score s and comparison to population and or other subjects.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Psychiatry (AREA)
- Physiology (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Signal Processing (AREA)
- Neurology (AREA)
- Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Developmental Disabilities (AREA)
- Neurosurgery (AREA)
- Evolutionary Computation (AREA)
- Fuzzy Systems (AREA)
- Mathematical Physics (AREA)
- High Energy & Nuclear Physics (AREA)
- Optics & Photonics (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Educational Technology (AREA)
- Social Psychology (AREA)
- Power Engineering (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Radar Systems Or Details Thereof (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14193106 | 2014-11-13 | ||
PCT/EP2015/076629 WO2016075324A1 (en) | 2014-11-13 | 2015-11-13 | Scoring method based on improved signals analysis |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3217869A1 true EP3217869A1 (en) | 2017-09-20 |
EP3217869B1 EP3217869B1 (en) | 2022-05-25 |
Family
ID=51904752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15797939.4A Active EP3217869B1 (en) | 2014-11-13 | 2015-11-13 | Scoring method based on improved signals analysis |
Country Status (7)
Country | Link |
---|---|
US (1) | US11116437B2 (en) |
EP (1) | EP3217869B1 (en) |
JP (1) | JP2017537686A (en) |
KR (1) | KR20170086056A (en) |
CN (1) | CN107106069A (en) |
BR (1) | BR112017009991A2 (en) |
WO (1) | WO2016075324A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3335630A1 (en) * | 2016-12-15 | 2018-06-20 | Mensia Technologies | Improved signal quality index of multichannel bio-signal using riemannian geometry |
US20190073605A1 (en) * | 2017-02-27 | 2019-03-07 | Andrew Jay KELLER | Systems and methods for real-time neural command classification and task execution |
US10713563B2 (en) * | 2017-11-27 | 2020-07-14 | Technische Universiteit Eindhoven | Object recognition using a convolutional neural network trained by principal component analysis and repeated spectral clustering |
EP3709870A1 (en) * | 2017-12-22 | 2020-09-23 | Bioserenity | System and method for calculation of an index of brain activity |
CN109657642A (en) * | 2018-12-29 | 2019-04-19 | 山东建筑大学 | A kind of Mental imagery Method of EEG signals classification and system based on Riemann's distance |
US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
CN110320411A (en) * | 2019-07-05 | 2019-10-11 | 北京无线电计量测试研究所 | A kind of impulse amplitude uncertainty modification method |
CN111615046B (en) * | 2020-05-11 | 2021-08-24 | 腾讯音乐娱乐科技(深圳)有限公司 | Audio signal processing method and device and computer readable storage medium |
CN111723661B (en) * | 2020-05-18 | 2023-06-16 | 广州光达创新科技有限公司 | Brain-computer interface migration learning method based on manifold embedded distribution alignment |
US20220101981A1 (en) * | 2020-09-28 | 2022-03-31 | xSensa Labs | Method and system for neuromodulation |
EP4412517A1 (en) * | 2021-10-08 | 2024-08-14 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Multimodal method for detecting a change in a patient's physiological condition and device for monitoring a patient so as to implement such a method |
CN114224341B (en) * | 2021-12-02 | 2023-12-15 | 浙大宁波理工学院 | Wearable forehead electroencephalogram-based depression rapid diagnosis and screening system and method |
CN113951887B (en) * | 2021-12-22 | 2022-03-25 | 北京航空航天大学杭州创新研究院 | Frequency spectrum matching independent component analysis method and system |
CN114548166A (en) * | 2022-02-18 | 2022-05-27 | 广州大学 | Electroencephalogram signal heterogeneous tag space migration learning method based on Riemann manifold |
CN117349603B (en) * | 2023-12-06 | 2024-03-12 | 小舟科技有限公司 | Adaptive noise reduction method and device for electroencephalogram signals, equipment and storage medium |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5355889A (en) * | 1992-06-09 | 1994-10-18 | Albert Eisenstein Health Care Foundation | Monitoring system for producing patient status indicator |
EP1702558A1 (en) * | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Method and device for the assessment of bowel function |
GB2465230B (en) * | 2008-11-17 | 2013-08-21 | Dialog Devices Ltd | Assessing a subject's circulatory system |
US8280839B2 (en) * | 2010-02-25 | 2012-10-02 | Mitsubishi Electric Research Laboratories, Inc. | Nearest neighbor methods for non-Euclidean manifolds |
FR2962821B1 (en) | 2010-07-13 | 2013-02-22 | Commissariat Energie Atomique | METHOD AND SYSTEM FOR CLASSIFYING NEURAL SIGNALS, AND METHOD FOR SELECTING ELECTRODES FOR DIRECT NEURONAL CONTROL. |
CN102179001A (en) * | 2011-04-25 | 2011-09-14 | 暨南大学 | Sleep therapy apparatus based on electroencephalogram biofeedback and control method thereof |
FR2990124B1 (en) * | 2012-05-03 | 2014-04-25 | Univ Paris Curie | METHOD FOR CHARACTERIZING THE PHYSIOLOGICAL STATUS OF A PATIENT FROM ANALYSIS OF ITS BRAIN ELECTRICAL ACTIVITY, AND MONITORING DEVICE USING THE SAME |
CA2935813C (en) * | 2013-01-08 | 2021-12-21 | Interaxon Inc. | Adaptive brain training computer system and method |
US20140303424A1 (en) * | 2013-03-15 | 2014-10-09 | Iain Glass | Methods and systems for diagnosis and treatment of neural diseases and disorders |
CN104825159B (en) * | 2015-04-23 | 2017-08-22 | 张鸣沙 | Brain electricity is with frequency detection method, brain electricity with frequency stimulating method and device |
-
2015
- 2015-11-13 WO PCT/EP2015/076629 patent/WO2016075324A1/en active Application Filing
- 2015-11-13 EP EP15797939.4A patent/EP3217869B1/en active Active
- 2015-11-13 CN CN201580072469.9A patent/CN107106069A/en active Pending
- 2015-11-13 BR BR112017009991-8A patent/BR112017009991A2/en not_active Application Discontinuation
- 2015-11-13 JP JP2017525401A patent/JP2017537686A/en active Pending
- 2015-11-13 US US15/526,351 patent/US11116437B2/en active Active
- 2015-11-13 KR KR1020177015061A patent/KR20170086056A/en unknown
Non-Patent Citations (2)
Title |
---|
None * |
See also references of WO2016075324A1 * |
Also Published As
Publication number | Publication date |
---|---|
US20170311832A1 (en) | 2017-11-02 |
EP3217869B1 (en) | 2022-05-25 |
WO2016075324A1 (en) | 2016-05-19 |
BR112017009991A2 (en) | 2018-02-14 |
CN107106069A (en) | 2017-08-29 |
US11116437B2 (en) | 2021-09-14 |
JP2017537686A (en) | 2017-12-21 |
KR20170086056A (en) | 2017-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3217869B1 (en) | Scoring method based on improved signals analysis | |
US11253701B2 (en) | Transcranial stimulation device and method based on electrophysiological testing | |
Casson et al. | Electroencephalogram | |
JP6454944B2 (en) | Configuration and spatial arrangement of front electrode sensor for detecting physiological signals | |
US20200038653A1 (en) | Multimodal closed-loop brain-computer interface and peripheral stimulation for neuro-rehabilitation | |
Paek et al. | Decoding repetitive finger movements with brain activity acquired via non-invasive electroencephalography | |
Murugappan et al. | Inferring of human emotional states using multichannel EEG | |
Lisi et al. | EEG single-trial detection of gait speed changes during treadmill walk | |
Nezam et al. | A novel classification strategy to distinguish five levels of pain using the EEG signal features | |
Hosseini et al. | Emotional stress recognition system for affective computing based on bio-signals | |
US20160029946A1 (en) | Wavelet analysis in neuro diagnostics | |
JP2015533559A (en) | Systems and methods for perceptual and cognitive profiling | |
WO2014150684A1 (en) | Artifact as a feature in neuro diagnostics | |
Bigliassi et al. | Effects of auditory distraction on voluntary movements: exploring the underlying mechanisms associated with parallel processing | |
Baghdadi et al. | Dasps: a database for anxious states based on a psychological stimulation | |
Pun et al. | Brain-computer interaction research at the Computer Vision and Multimedia Laboratory, University of Geneva | |
Ketu et al. | Hybrid classification model for eye state detection using electroencephalogram signals | |
Khalid et al. | Epileptic MEG spikes detection using amplitude thresholding and dynamic time warping | |
Chakraborty et al. | A survey on Internet-of-Thing applications using electroencephalogram | |
CN113614751A (en) | Electroencephalogram signal identification and extraction | |
Munavalli et al. | Introduction to Brain–Computer Interface: Applications and Challenges | |
Kaur et al. | Analyzing eeg based neurological phenomenon in bci systems | |
Geethanjali | Fundamentals of brain signals and its medical application using data analysis techniques | |
Czyżewski et al. | Multifactor consciousness level assessment of participants with acquired brain injuries employing human–computer interfaces | |
US20210045645A1 (en) | Method and system for mapping brain dysfunction for psychiatric and neurological disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20170613 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20200114 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602015079175 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A61B0005048200 Ipc: A61B0005375000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61B 5/375 20210101AFI20210827BHEP |
|
INTG | Intention to grant announced |
Effective date: 20211004 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CYREBRO TECHNOLOGIES |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1493933 Country of ref document: AT Kind code of ref document: T Effective date: 20220615 Ref country code: DE Ref legal event code: R096 Ref document number: 602015079175 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20220525 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1493933 Country of ref document: AT Kind code of ref document: T Effective date: 20220525 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220926 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220825 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220826 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220825 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220925 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602015079175 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20230228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230511 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20221130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221130 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221113 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221113 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221130 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231123 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20231120 Year of fee payment: 9 Ref country code: DE Payment date: 20231121 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20151113 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220525 |